Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115915 N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
05/10/2012US20120115914 Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine
05/10/2012US20120115913 Ethanamine Compounds and Methods of Using the Same
05/10/2012US20120115912 Rxr agonist compounds and methods
05/10/2012US20120115910 Compositions and methods for treating parkinson's disease
05/10/2012US20120115908 Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
05/10/2012US20120115907 Novel compounds as inhibitors of renin
05/10/2012US20120115906 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
05/10/2012US20120115905 Nitrone, Nitroso, and Nitroxide Spintraps and Spin Labels and Their Hydroxylamines
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115900 Substituted naphthyridine derivatives and their medical use
05/10/2012US20120115897 Aryl (Ethanoic) Propanoic Acid Ascorbyl Ester, Preparation Method Thereof And Medicament Containing The Same
05/10/2012US20120115895 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/10/2012US20120115894 Imidazole derivatives useful as modulators of faah and as faah imaging agents
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115891 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115885 Quinolinone PDE2 Inhibitors
05/10/2012US20120115882 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/10/2012US20120115881 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
05/10/2012US20120115879 Method of treatment for mental disorders
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115871 Method of treatment of depression
05/10/2012US20120115868 Novel triazole compounds ii
05/10/2012US20120115865 New Salts of an Indole Derivative and Their Use in Medicine
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115863 Compounds for the treatment of cns disorders
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115860 Novel derivatives of aryl--methanone, their method of preparation and their use as medicinal products
05/10/2012US20120115856 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
05/10/2012US20120115854 Pharmaceutical composition containing antihypertensive agents
05/10/2012US20120115850 Substituted arylamine compounds and methods of treatment
05/10/2012US20120115849 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
05/10/2012US20120115848 Inhibitors of Polo-Like Kinase
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115844 Novel triazole compounds i
05/10/2012US20120115842 Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115839 Use of selective gaba a alpha 5 negative allosteric modulators for the treatment of central nervous system conditions
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115827 3-aminobenzamide compounds and vanilloid receptor subtype 1 (vr1) inhibitors
05/10/2012US20120115826 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115823 Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
05/10/2012US20120115822 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders
05/10/2012US20120115815 Compositions useful especially for treatment or prevention of metabolic syndrome
05/10/2012US20120115811 Phenylanaline amide derivatives useful for treating insulin-related diseases and conditions
05/10/2012US20120115799 Pharmaceutical formulations
05/10/2012US20120115791 Methods for Treating Immune Mediated Neurological Diseases
05/10/2012US20120115790 Therapeutic approach to neurodegenerative disorders using a tfp5-peptide
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115772 Conjugation method
05/10/2012US20120115771 Carrier
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120114767 System and Method for Diagnosis and Treatment of Neuropsychiatric Disorders
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114741 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114677 Modified nicotinic compounds and related methods
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114669 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
05/10/2012US20120114666 Neurological autoimmune disorders
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114650 Single chain antibodies against beta-amyloid peptide
05/10/2012US20120114635 Antibodies to cross-linked amyloid beta oligomers
05/10/2012US20120114626 Method for treating pervasive development disorders
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114618 Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification
05/10/2012US20120114616 Olfactory stem cells and uses thereof
05/10/2012US20120114595 Sugar chain-added ailim extracellular domain and method for producing same
05/10/2012US20120114562 Method for treating pervasive development disorders
05/10/2012US20120114561 Methods for the treatment of neurodegenerative disorders
05/10/2012US20120114560 Abeta binding molecules
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120114555 Method for treating immune disorders
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/10/2012CA2816911A1 Novel treatment of multiple sclerosis (ms)
05/10/2012CA2816834A1 A2a antagonists as cognition and motor function enhancers
05/10/2012CA2816363A1 7-(1,2,3-triazol-4-yl)pyrrolo[2,3-b]pyrazine derivatives
05/10/2012CA2816181A1 Dihydrooxazol-2-amine derivatives
05/10/2012CA2815964A1 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
05/10/2012CA2815959A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
05/10/2012CA2812664A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions
05/10/2012CA2811948A1 Methods for treatment of brain injury utilizing biologics
05/09/2012EP2450360A2 (S)-N-Methylnaltrexone
05/09/2012EP2450359A2 (R)-N-Methylnaltrexone
05/09/2012EP2450358A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2450346A1 Antagonists of the TRPV1 receptor and uses thereof
05/09/2012EP2450039A1 Dosing regimen for sedation with CNS 7056 (Remimazolam)
05/09/2012EP2448970A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
05/09/2012EP2448931A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448928A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/09/2012EP2448922A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 1833